Procter & Gamble Hygiene & Health Care Ltd.

Procter & Gamble Hygiene & Health Care Ltd. has touched a new 52-week low of Rs.12000 today, marking a significant decline amid broader market fluctuations and sectoral underperformance. The stock has been on a downward trajectory, reflecting a combination of valuation concerns and recent financial trends.

Procter & Gamble Hygiene & Health Care Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Oct 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 January 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Procter & Gamble Hygiene & Health Care Ltd. has declined to a fresh 52-week low of Rs.12,118.4, marking a significant downturn amid broader market fluctuations and persistent underperformance relative to its sector and benchmark indices.

Procter & Gamble Hygiene & Health Care Ltd. is rated Sell by MarketsMOJO. This rating was last updated on 07 October 2024. However, the analysis and financial metrics presented here reflect the stock's current position as of 09 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Procter & Gamble Hygiene & Health Care Ltd. has experienced a notable shift in price momentum, with technical indicators signalling a bearish trend across multiple timeframes. The company’s stock price has declined modestly in recent sessions, reflecting deteriorating market sentiment amid broader FMCG sector dynamics and relative underperformance against benchmark indices.

Procter & Gamble Hygiene & Health Care Ltd. (P&G Hygiene) has experienced a subtle shift in its technical momentum as of early January 2026, with key indicators signalling a transition from bearish to mildly bearish territory. Despite a modest day gain of 0.56%, the stock’s technical parameters reveal a complex picture of mixed signals across weekly and monthly timeframes, prompting a cautious stance among investors.

Procter & Gamble Hygiene & Health Care Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Oct 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 December 2025, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

P&G Hygiene’s market evaluation has undergone a revision reflecting shifts in its fundamental and technical outlook. The company, positioned within the FMCG sector as a midcap entity, faces a complex environment marked by valuation concerns and subdued financial momentum, influencing its recent assessment.

P&G Hygiene's market evaluation has undergone a revision reflecting shifts in its fundamental and technical outlook. The changes come amid subdued financial trends and valuation concerns, impacting investor sentiment in the midcap FMCG sector.

Procter & Gamble Hygiene & Health Care reported a flat performance for the quarter ending September 2025, despite a significant profit after tax growth of 37.19% over six months. However, cash reserves have declined, raising concerns about liquidity, while the stock has underperformed compared to the broader market.

Procter & Gamble Hygiene & Health Care Ltd. (P&G Hygiene), the Indian arm of the global FMCG giant, reported a net profit of ₹209.86 crores for Q2 FY26 (July-September 2025), marking a modest sequential improvement of 9.27% from Q1 FY26's ₹192.06 crores but virtually flat year-on-year growth of just 0.95% from ₹211.90 crores in Q2 FY25. The muted performance has weighed on investor sentiment, with the stock trading at ₹13,230.10 as of November 6, 2025, down 1.34% on the day and reflecting a concerning 16.81% decline over the past year. With a market capitalisation of ₹43,347 crores, the company's premium valuation multiple of 53x trailing earnings faces increasing scrutiny amid decelerating growth momentum.

Procter & Gamble Hygiene & Health Care has recently revised its evaluation amid changing market conditions. The stock has seen an 18.08% decline over the past year, contrasting with the Sensex's positive return. Technical indicators present a mixed outlook, reflecting the company's challenges in a competitive FMCG sector.

Procter & Gamble Hygiene & Health Care has experienced notable stock price fluctuations, currently at 13,430.00. The company faces mixed technical indicators, with some suggesting caution. Compared to the Sensex, P&G has underperformed recently, indicating potential challenges in market positioning and performance metrics.

Procter & Gamble Hygiene & Health Care has recently revised its evaluation amid changing market dynamics. The stock price has seen a slight increase, but it has declined significantly over the past year. Technical indicators present mixed signals, reflecting a challenging performance compared to the Sensex.